;PMID: 9972481
;source_file_826.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..79] = [t:0..79]
;1)sentence:[e:85..227] = [t:85..227]
;2)section:[e:231..277] = [t:231..277]
;3)section:[e:281..342] = [t:281..342]
;4)sentence:[e:346..601] = [t:346..601]
;5)sentence:[e:602..826] = [t:602..826]
;6)sentence:[e:827..924] = [t:827..924]
;7)sentence:[e:925..1098] = [t:925..1098]
;8)sentence:[e:1100..1201] = [t:1100..1201]
;9)sentence:[e:1202..1281] = [t:1202..1281]
;10)sentence:[e:1282..1373] = [t:1282..1373]
;11)sentence:[e:1374..1481] = [t:1374..1481]
;12)sentence:[e:1482..1589] = [t:1482..1589]
;13)sentence:[e:1590..1696] = [t:1590..1696]
;14)sentence:[e:1697..1785] = [t:1697..1785]
;15)sentence:[e:1786..2014] = [t:1786..2014]
;16)section:[e:2018..2062] = [t:2018..2062]

;section 0 Span:0..79
;Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 
;Nov;121(1-3):405-12.
(SEC
  (FRAG (NNP:[0..4] Comp) (NNP:[5..12] Biochem) (NNP:[13..20] Physiol)
        (NNP:[21..22] C) (NNP:[23..32] Pharmacol) (NNP:[33..40] Toxicol)
        (DT:[41..51] Endocrinol) (JJ:[51..52] .) (CD:[53..57] 1998)
        (CD:[59..67] Nov;121-LRB-) (CD:[67..68] 1) (HYPH:[68..69] -)
        (CD:[69..70] 3) (HYPH:[70..71] -RRB-) (CD:[71..75] :405)
        (HYPH:[75..76] -) (CD:[76..78] 12) (.:[78..79] .)))

;sentence 1 Span:85..227
;CYP1A-catalyzed uroporphyrinogen oxidation in hepatic microsomes from 
;non-mammalian vertebrates (chick and duck embryos, scup and alligator).
;[85..90]:cyp450:"CYP1A"
;[101..117]:substance:"uroporphyrinogen"
(SENT
  (NP-HLN
    (NP
      (ADJP (NN:[85..90] CYP1A) (HYPH:[90..91] -) (VBN:[91..100] catalyzed))
      (NN:[101..117] uroporphyrinogen) (NN:[118..127] oxidation))
    (PP-LOC (IN:[128..130] in)
      (NP
        (NP (JJ:[131..138] hepatic) (NNS:[139..149] microsomes))
        (PP (IN:[150..154] from)
          (NP
            (ADJP (AFX:[156..159] non) (HYPH:[159..160] -)
                  (JJ:[160..169] mammalian))
            (NNS:[170..181] vertebrates)
            (PRN (-LRB-:[182..183] -LRB-)
              (NP
                (NP
                  (NP (NN:[183..188] chick)
                    (NML-1 (-NONE-:[188..188] *P*)))
                  (CC:[189..192] and)
                  (NP (NN:[193..197] duck)
                    (NML-1 (NNS:[198..205] embryos))))
                (,:[205..206] ,)
                (NP (NN:[207..211] scup) (CC:[212..215] and)
                    (NN:[216..225] alligator)))
              (-RRB-:[225..226] -RRB-))))))
    (.:[226..227] .)))

;section 2 Span:231..277
;Gorman N, Walton HS, Sinclair JF, Sinclair PR.
(SEC
  (FRAG (NNP:[231..237] Gorman) (NNP:[238..239] N) (,:[239..240] ,)
        (NNP:[241..247] Walton) (NNP:[248..250] HS) (,:[250..251] ,)
        (NNP:[252..260] Sinclair) (NNP:[261..263] JF) (,:[263..264] ,)
        (NNP:[265..273] Sinclair) (NNP:[274..277] PR.)))

;section 3 Span:281..342
;VA Medical Center (151), White River Junction, VT 05009, USA.
(SEC
  (FRAG (NNP:[281..283] VA) (NNP:[284..291] Medical) (NNP:[292..298] Center)
        (-LRB-:[299..300] -LRB-) (CD:[300..303] 151) (-RRB-:[303..304] -RRB-)
        (,:[304..305] ,) (NNP:[306..311] White) (NNP:[312..317] River)
        (NNP:[318..326] Junction) (,:[326..327] ,) (NNP:[328..330] VT)
        (CD:[331..336] 05009) (,:[336..337] ,) (NNP:[338..341] USA)
        (.:[341..342] .)))

;sentence 4 Span:346..601
;Uroporphyrin (URO) accumulation in the liver of animals treated with 
;polyhalogenated aromatic hydrocarbons (PHAH) is associated with increased 
;microsomal oxidation of uroporphyrinogen catalyzed by rodent CYP1A2 and by a 
;similar form in chicken, CYP1A5.
;[346..358]:substance:"Uroporphyrin"
;[360..363]:substance:"URO"
;[416..453]:substance:"polyhalogenated aromatic hydrocarbons"
;[455..459]:substance:"PHAH"
;[515..531]:substance:"uroporphyrinogen"
;[552..558]:cyp450:"CYP1A2"
;[594..600]:cyp450:"CYP1A5"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NML
          (NML (NN:[346..358] Uroporphyrin))
          (NML (-LRB-:[359..360] -LRB-) (NN:[360..363] URO)
               (-RRB-:[363..364] -RRB-)))
        (NN:[365..377] accumulation))
      (PP-LOC (IN:[378..380] in)
        (NP
          (NP (DT:[381..384] the) (NN:[385..390] liver))
          (PP (IN:[391..393] of)
            (NP
              (NP (NNS:[394..401] animals))
              (VP (VBN:[402..409] treated)
                (NP (-NONE-:[409..409] *))
                (PP-MNR (IN:[410..414] with)
                  (NP
                    (NP (VBN:[416..431] polyhalogenated)
                        (JJ:[432..440] aromatic) (NNS:[441..453] hydrocarbons))
                    (NP (-LRB-:[454..455] -LRB-) (NN:[455..459] PHAH)
                        (-RRB-:[459..460] -RRB-))))))))))
    (VP (VBZ:[461..463] is)
      (VP (VBN:[464..474] associated)
        (NP-1 (-NONE-:[474..474] *))
        (PP-CLR (IN:[475..479] with)
          (NP
            (NP
              (NP (VBN:[480..489] increased) (JJ:[491..501] microsomal)
                  (NN:[502..511] oxidation))
              (PP (IN:[512..514] of)
                (NP (NN:[515..531] uroporphyrinogen))))
            (VP (VBN:[532..541] catalyzed)
              (NP (-NONE-:[541..541] *))
              (PP
                (PP (IN:[542..544] by)
                  (NP-LGS (NN:[545..551] rodent) (NN:[552..558] CYP1A2)))
                (CC:[559..562] and)
                (PP (IN:[563..565] by)
                  (NP-LGS
                    (NP
                      (NP (DT:[566..567] a) (JJ:[569..576] similar)
                          (NN:[577..581] form))
                      (PP-LOC (IN:[582..584] in)
                        (NP (NN:[585..592] chicken))))
                    (,:[592..593] ,)
                    (NP (NN:[594..600] CYP1A5))))))))))
    (.:[600..601] .)))

;sentence 5 Span:602..826
;The planar biphenyl,  3,3',4,4'-tetrachlorobiphenyl (TCB) stimulates
;uroporphyrinogen oxidation (UROX)  in chick hepatic microsomes, but inhibits
;UROX activity in hepatic microsomes  from mice and rats pre-induced by
;CYP1A2.
;[613..621]:substance:"biphenyl"
;[624..653]:substance:"3,3',4,4'-tetrachlorobiphenyl"
;[655..658]:substance:"TCB"
;[671..687]:substance:"uroporphyrinogen"
;[819..825]:cyp450:"CYP1A2"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[602..605] The) (JJ:[606..612] planar) (NN:[613..621] biphenyl))
      (,:[621..622] ,)
      (NP
        (NP (NN:[624..653] 3,3',4,4'-tetrachlorobiphenyl))
        (NP (-LRB-:[654..655] -LRB-) (NN:[655..658] TCB)
            (-RRB-:[658..659] -RRB-))))
    (VP
      (VP (VBZ:[660..670] stimulates)
        (NP
          (NP (NN:[671..687] uroporphyrinogen) (NN:[688..697] oxidation))
          (NP (-LRB-:[698..699] -LRB-) (NN:[699..703] UROX)
              (-RRB-:[703..704] -RRB-)))
        (PP-LOC (IN:[706..708] in)
          (NP (NN:[709..714] chick) (JJ:[715..722] hepatic)
              (NNS:[723..733] microsomes))))
      (,:[733..734] ,) (CC:[735..738] but)
      (VP (VBZ:[739..747] inhibits)
        (NP (NN:[748..752] UROX) (NN:[753..761] activity))
        (PP-LOC (IN:[762..764] in)
          (NP
            (NP (JJ:[765..772] hepatic) (NNS:[773..783] microsomes))
            (PP (IN:[785..789] from)
              (NP
                (NP (NNS:[790..794] mice) (CC:[795..798] and)
                    (NNS:[799..803] rats))
                (VP (AFX:[804..807] pre) (HYPH:[807..808] -)
                    (VBN:[808..815] induced)
                  (NP (-NONE-:[815..815] *))
                  (PP (IN:[816..818] by)
                    (NP-LGS (NN:[819..825] CYP1A2))))))))))
    (.:[825..826] .)))

;sentence 6 Span:827..924
;Here we investigated whether TCB would  stimulate or inhibit UROX in other
;non-mammalian species.
;[856..859]:substance:"TCB"
(SENT
  (S
    (ADVP (RB:[827..831] Here))
    (NP-SBJ (PRP:[832..834] we))
    (VP (VBD:[835..847] investigated)
      (SBAR (IN:[848..855] whether)
        (S
          (NP-SBJ (NN:[856..859] TCB))
          (VP (MD:[860..865] would)
            (VP (VB:[867..876] stimulate) (CC:[877..879] or)
                (VB:[880..887] inhibit)
              (NP (NN:[888..892] UROX))
              (PP-LOC (IN:[893..895] in)
                (NP (JJ:[896..901] other)
                  (ADJP (AFX:[902..905] non) (HYPH:[905..906] -)
                        (JJ:[906..915] mammalian))
                  (NNS:[916..923] species))))))))
    (.:[923..924] .)))

;sentence 7 Span:925..1098
;UROX was stimulated  1.5-3-fold by TCB and 2-4-fold by
;3,3',4,4',5,5'-hexachlorobiphenyl in hepatic  microsomes from duck, alligator
;and scup treated with inducers of CYP1A.
;[946..956]:quantitative-value:"1.5-3-fold"
;[960..963]:substance:"TCB"
;[968..976]:quantitative-value:"2-4-fold"
;[980..1013]:substance:"3,3',4,4',5,5'-hexachlorobiphenyl"
;[1080..1088]:substance:"inducers"
;[1092..1097]:cyp450:"CYP1A"
(SENT
  (S
    (NP-SBJ-1 (NN:[925..929] UROX))
    (VP (VBD:[930..933] was)
      (VP
        (VP (VBN:[934..944] stimulated)
          (NP-1 (-NONE-:[944..944] *))
          (ADVP-EXT
            (QP (CD:[946..949] 1.5) (HYPH:[949..950] -) (CD:[950..951] 3))
            (HYPH:[951..952] -) (RB:[952..956] fold))
          (PP (IN:[957..959] by)
            (NP-LGS (NN:[960..963] TCB))))
        (CC:[964..967] and)
        (VP
          (ADVP-EXT
            (QP (CD:[968..969] 2) (HYPH:[969..970] -) (CD:[970..971] 4))
            (HYPH:[971..972] -) (RB:[972..976] fold))
          (PP (IN:[977..979] by)
            (NP-LGS (NN:[980..1013] 3,3',4,4',5,5'-hexachlorobiphenyl))))
        (PP-LOC (IN:[1014..1016] in)
          (NP
            (NP (JJ:[1017..1024] hepatic) (NNS:[1026..1036] microsomes))
            (PP (IN:[1037..1041] from)
              (NP
                (NP (NN:[1042..1046] duck) (,:[1046..1047] ,)
                    (NN:[1048..1057] alligator) (CC:[1058..1061] and)
                    (NN:[1062..1066] scup))
                (VP (VBN:[1067..1074] treated)
                  (NP (-NONE-:[1074..1074] *))
                  (PP-CLR (IN:[1075..1079] with)
                    (NP
                      (NP (NNS:[1080..1088] inducers))
                      (PP (IN:[1089..1091] of)
                        (NP (NN:[1092..1097] CYP1A))))))))))))
    (.:[1097..1098] .)))

;sentence 8 Span:1100..1201
;Hexachlorobenzene stimulated chick UROX, but was ineffective with microsomes 
;from the other species.
;[1100..1117]:substance:"Hexachlorobenzene"
(SENT
  (S
    (NP-SBJ (NN:[1100..1117] Hexachlorobenzene))
    (VP
      (VP (VBD:[1118..1128] stimulated)
        (NP (NN:[1129..1134] chick) (NN:[1135..1139] UROX)))
      (,:[1139..1140] ,) (CC:[1141..1144] but)
      (VP (VBD:[1145..1148] was)
        (ADJP-PRD (JJ:[1149..1160] ineffective))
        (PP (IN:[1161..1165] with)
          (NP
            (NP (NNS:[1166..1176] microsomes))
            (PP (IN:[1178..1182] from)
              (NP (DT:[1183..1186] the) (JJ:[1187..1192] other)
                  (NNS:[1193..1200] species)))))))
    (.:[1200..1201] .)))

;sentence 9 Span:1202..1281
;The stimulation of UROX by TCB was also observed in  chick hepatocyte
;cultures.
;[1229..1232]:substance:"TCB"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1202..1205] The) (NN:[1206..1217] stimulation))
      (PP (IN:[1218..1220] of)
        (NP (NN:[1221..1225] UROX)))
      (PP (IN:[1226..1228] by)
        (NP (NN:[1229..1232] TCB))))
    (VP (VBD:[1233..1236] was)
      (ADVP (RB:[1237..1241] also))
      (VP (VBN:[1242..1250] observed)
        (NP-1 (-NONE-:[1250..1250] *))
        (PP-LOC (IN:[1251..1253] in)
          (NP (NN:[1255..1260] chick) (NN:[1261..1271] hepatocyte)
              (NNS:[1272..1280] cultures)))))
    (.:[1280..1281] .)))

;sentence 10 Span:1282..1373
;Pretreatment with up to 5 nM TCB induced CYP1A, but  did not result in
;accumulation of URO.
;[1306..1307]:quantitative-value:"5"
;[1308..1310]:quantitative-units:"nM"
;[1311..1314]:substance:"TCB"
;[1323..1328]:cyp450:"CYP1A"
;[1369..1372]:substance:"URO"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1282..1294] Pretreatment))
      (PP (IN:[1295..1299] with)
        (NP
          (NML
            (QP (IN:[1300..1302] up) (TO:[1303..1305] to) (CD:[1306..1307] 5))
            (NN:[1308..1310] nM))
          (NN:[1311..1314] TCB))))
    (VP
      (VP (VBD:[1315..1322] induced)
        (NP (NN:[1323..1328] CYP1A)))
      (,:[1328..1329] ,) (CC:[1330..1333] but)
      (VP (VBD:[1335..1338] did) (RB:[1339..1342] not)
        (VP (VB:[1343..1349] result)
          (PP-CLR (IN:[1350..1352] in)
            (NP
              (NP (NN:[1353..1365] accumulation))
              (PP (IN:[1366..1368] of)
                (NP (NN:[1369..1372] URO))))))))
    (.:[1372..1373] .)))

;sentence 11 Span:1374..1481
;However, URO did accumulate if additional  (post-induction) TCB was added
;along with 5-aminolevulinic acid.
;[1383..1386]:substance:"URO"
;[1434..1437]:substance:"TCB"
;[1459..1480]:substance:"5-aminolevulinic acid"
(SENT
  (S
    (ADVP (RB:[1374..1381] However))
    (,:[1381..1382] ,)
    (NP-SBJ (NN:[1383..1386] URO))
    (VP (VBD:[1387..1390] did)
      (VP (VB:[1391..1401] accumulate)
        (SBAR-ADV (IN:[1402..1404] if)
          (S
            (NP-SBJ-1 (JJ:[1405..1415] additional)
              (PRN (-LRB-:[1417..1418] -LRB-)
                (NP (AFX:[1418..1422] post) (HYPH:[1422..1423] -)
                    (NN:[1423..1432] induction))
                (-RRB-:[1432..1433] -RRB-))
              (NN:[1434..1437] TCB))
            (VP (VBD:[1438..1441] was)
              (VP (VBN:[1442..1447] added)
                (NP-1 (-NONE-:[1447..1447] *))
                (PP
                  (ADVP (RB:[1448..1453] along))
                  (IN:[1454..1458] with)
                  (NP (JJ:[1459..1475] 5-aminolevulinic) (NN:[1476..1480] acid)))))))))
    (.:[1480..1481] .)))

;sentence 12 Span:1482..1589
;In this  post-inductional TCB treatment, cycloheximide was included to
;prevent further  induction of CYP1A.
;[1508..1511]:substance:"TCB"
;[1523..1536]:substance:"cycloheximide"
;[1583..1588]:cyp450:"CYP1A"
(SENT
  (S
    (PP (IN:[1482..1484] In)
      (NP (DT:[1485..1489] this)
        (ADJP (AFX:[1491..1495] post) (HYPH:[1495..1496] -)
              (JJ:[1496..1507] inductional))
        (NN:[1508..1511] TCB) (NN:[1512..1521] treatment)))
    (,:[1521..1522] ,)
    (NP-SBJ-1 (NN:[1523..1536] cycloheximide))
    (VP (VBD:[1537..1540] was)
      (VP (VBN:[1541..1549] included)
        (NP-1 (-NONE-:[1549..1549] *))
        (S-PRP
          (NP-SBJ (-NONE-:[1549..1549] *))
          (VP (TO:[1550..1552] to)
            (VP (VB:[1553..1560] prevent)
              (NP
                (NP (JJ:[1561..1568] further) (NN:[1570..1579] induction))
                (PP (IN:[1580..1582] of)
                  (NP (NN:[1583..1588] CYP1A)))))))))
    (.:[1588..1589] .)))

;sentence 13 Span:1590..1696
;In duck hepatocytes, pretreatment with 25 nM TCB resulted in  URO
;accumulation from 5-aminolevulinic acid.
;[1629..1631]:quantitative-value:"25"
;[1632..1634]:quantitative-units:"nM"
;[1635..1638]:substance:"TCB"
;[1652..1655]:substance:"URO"
;[1674..1695]:substance:"5-aminolevulinic acid"
(SENT
  (S
    (PP-LOC (IN:[1590..1592] In)
      (NP (NN:[1593..1597] duck) (NNS:[1598..1609] hepatocytes)))
    (,:[1609..1610] ,)
    (NP-SBJ
      (NP (NN:[1611..1623] pretreatment))
      (PP (IN:[1624..1628] with)
        (NP
          (NML (CD:[1629..1631] 25) (NN:[1632..1634] nM))
          (NN:[1635..1638] TCB))))
    (VP (VBD:[1639..1647] resulted)
      (PP-CLR (IN:[1648..1650] in)
        (NP
          (NP (NN:[1652..1655] URO) (NN:[1656..1668] accumulation))
          (PP (IN:[1669..1673] from)
            (NP (JJ:[1674..1690] 5-aminolevulinic) (NN:[1691..1695] acid))))))
    (.:[1695..1696] .)))

;sentence 14 Span:1697..1785
;Post-induction TCB was not required  and caused no further increase in URO
;accumulation.
;[1712..1715]:substance:"TCB"
;[1768..1771]:substance:"URO"
(SENT
  (S
    (NP-SBJ-1
      (NML (AFX:[1697..1701] Post) (HYPH:[1701..1702] -)
           (NN:[1702..1711] induction))
      (NN:[1712..1715] TCB))
    (VP
      (VP (VBD:[1716..1719] was) (RB:[1720..1723] not)
        (VP (VBN:[1724..1732] required)
          (NP-1 (-NONE-:[1732..1732] *))))
      (CC:[1734..1737] and)
      (VP (VBN:[1738..1744] caused)
        (NP
          (NP (DT:[1745..1747] no) (JJ:[1748..1755] further)
              (NN:[1756..1764] increase))
          (PP (IN:[1765..1767] in)
            (NP (NN:[1768..1771] URO) (NN:[1772..1784] accumulation))))))
    (.:[1784..1785] .)))

;sentence 15 Span:1786..2014
;The differences in PHAH  stimulation of UROX among the non-mammalian species
;have implications in the  evolutionary changes in CYP1A, as well as the
;mechanism of development of  PHAH-stimulated uroporphyria in different
;species.
;[1805..1809]:substance:"PHAH"
;[1913..1918]:cyp450:"CYP1A"
;[1964..1968]:substance:"PHAH"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1786..1789] The) (NNS:[1790..1801] differences))
      (PP (IN:[1802..1804] in)
        (NP
          (NP (NN:[1805..1809] PHAH) (NN:[1811..1822] stimulation))
          (PP (IN:[1823..1825] of)
            (NP (NN:[1826..1830] UROX)))))
      (PP (IN:[1831..1836] among)
        (NP (DT:[1837..1840] the)
          (ADJP (AFX:[1841..1844] non) (HYPH:[1844..1845] -)
                (JJ:[1845..1854] mammalian))
          (NNS:[1855..1862] species))))
    (VP (VBP:[1863..1867] have)
      (NP
        (NP (NNS:[1868..1880] implications))
        (PP (IN:[1881..1883] in)
          (NP
            (NP
              (NP (DT:[1884..1887] the) (JJ:[1889..1901] evolutionary)
                  (NNS:[1902..1909] changes))
              (PP (IN:[1910..1912] in)
                (NP (NN:[1913..1918] CYP1A))))
            (,:[1918..1919] ,)
            (CONJP (RB:[1920..1922] as) (RB:[1923..1927] well)
                   (IN:[1928..1930] as))
            (NP
              (NP (DT:[1931..1934] the) (NN:[1935..1944] mechanism))
              (PP (IN:[1945..1947] of)
                (NP
                  (NP (NN:[1948..1959] development))
                  (PP (IN:[1960..1962] of)
                    (NP
                      (ADJP (NN:[1964..1968] PHAH) (HYPH:[1968..1969] -)
                            (VBN:[1969..1979] stimulated))
                      (NN:[1980..1992] uroporphyria)))))
              (PP-LOC (IN:[1993..1995] in)
                (NP (JJ:[1996..2005] different) (NNS:[2006..2013] species))))))))
    (.:[2013..2014] .)))

;section 16 Span:2018..2062
;PMID: 9972481 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2018..2022] PMID) (::[2022..2023] :) (CD:[2024..2031] 9972481)
        (-LRB-:[2032..2033] -LSB-) (NNP:[2033..2039] PubMed)
        (HYPH:[2040..2041] -) (NN:[2042..2049] indexed) (IN:[2050..2053] for)
        (NNP:[2054..2061] MEDLINE) (-RRB-:[2061..2062] -RSB-)))
